The People's Republic of China will celebrate its 70th anniversary on Tuesday, October 1. La Trobe University's China Studies Research Centre and La Trobe Asia will present a panel discussion in which some of Australia's leading China experts will review the PRC's highs and lows, its failures and its successes, through the 27 Mao Zedong years and the 43 years since then, of Deng Xiaoping's reform-and-opening followed by Xi Jinping's New Era for...
California-based PharmaCyte Biotech and the University of Technology Sydney (UTS) have signed a research agreement to develop a new version of Melligen cells that can potentially express higher levels of insulin.
Content Types: ArticleRegions & Countries: AustraliaIndustries: All
Part 1 of this blog analysed some of the trade-related aspects to Australia’s unprecedented 28-year run of uninterrupted economic growth. Our liberalised trade, our strategic links to Asia and our human capital have all played their part.
In May 2019, South Korean President, Moon Jae-in, announced an ‘Innovative Strategy on the Bio-health Industry’. This new strategy for bio-health will provide partnership and collaboration opportunities for Australian companies across various sectors including the commercialisation of research and development (R&D), clinical trials and digital health.
Amid the global trade and tariffs war between China and the US, Asian markets saw a deterioration in M&A activity in 2Q19. In line with the overall trend in the region, private equity activity decreased for the third consecutive quarter.